Tuesday, January 15, 2013

Table of Contents

Abstract Discontinuing Risperidone Linked to Agitation in Alzheimer's Prenatal Antidepressant Exposure Not Linked to Intellectual, Behavioral Effects Rhabdomyolysis Linked to Pregabalin and Simvastatin Bipolar Patients at Higher Risk for Adverse Pregnancy Outcomes FDA: Benefits of New Obesity Drugs Greater than Risks Study Examines Risk for Cardiovascular Events of Varenicline vs. Bupropion Scopolamine Augmentation for Moderate to Severe Depression N‐acetylcysteine as an Add‐On Treatment for OCD Memantine Augmentation for Moderate to Severe OCD Discontinuation Paxil Labeling Revision (Source: The Brown University Psychopharmacology Update)

MedWorm Sponsor Message: Have a look at The Psychiatry Daily, the new psychiatry portal powered by MedWorm, with all the latest psychiatry news and research updated daily.





via Original Article

No comments:

Post a Comment